Scientists at the University of Copenhagen, Denmark, led the research, which found that while the detection of male microchimerism was associated with the increased risk of developing colon cancer, it is also associated with reduced risk of developing breast cancer.
“Fetal microchimerism may be highly relevant to later cancer development,” said Vijayakrishna K. (V.K.) Gadi, MD, PhD, an assistant member of the clinical research division at Fred Hutchinson Cancer Research Center and senior author of a study, in the release. “However, the study does not allow us to identify the underlying biological mechanisms.”
Related Articles on Colon Cancer:
Gastroenterologist Dr. John Gray Receives Nevada Community Service Award
Managed Care, Market Competition Drive Up Likelihood of Colon Procedures
Gastroenterologist Dr. Shaily Jain Writes Column on Importance of Colonoscopies for Women
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
